Safety and Efficacy of IV Diazoxide as an Additive to Hyperkalemic Cardioplegia in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

NCT04830982 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawn in IRB.

Conditions

Myocardial Stunning

Interventions

DRUG: IV Diazoxide
OTHER: Placebo

Sponsor

Johns Hopkins University